DUK Q1 2026 Earnings Utility Giant Beats Estimates as Regulatory Gains Offset Cost Pressures Purple Biotech Q1 2025 Earnings DevelopmentStage Focus Drives Investor Sentiment FUL Q1 2026 Earnings EPS Beats Estimates Shares Rise 228 COTY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Revenue Data Unavailable ASRV Q1 2026 Earnings Positive EPS Reported Amid Quiet Quarter CNP Q1 2026 Earnings Slight EPS Miss but Stock Gains on Operational Stability